ASCO Ovarian Cancer News:
Drug keeps ovarian cancer in check, study finds
In a study of 1,873 women with untreated ovarian cancer, Avastin extended progression-free survival by 39% compared with standard chemotherapy alone.
Read this article by Thomas H. Maugh II of the Los Angeles Times on the Chicago Tribune’s Website (not quite sure why) by going to:
Avastin Extends Progression-Free Survival.
Feel good and keep smiling! Pat